Improving Care for Rural Patients With Solid Tumors

Conditions

• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colon Cancer
• Head and Neck Cancer
• Lung Cancer
• Rectum Cancer
• Thyroid Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - 99 Years

Healthy Volunteers

Not accepted

Interventions

• CARES Intervention — BEHAVIORAL
  Nurse navigators and masters levels counselors will meet with participants up to 10 times each (10 navigation and 10 counseling) over a 6 month period. The number of sessions will be determined by the length of the patient's treatment. The timing of each session will be guided by a regular assessment to reduce the time from diagnosis to initiation of treatment and the time between subsequent treatments. Sessions will occur at key transition points during treatment to target the factors associated with treatment delays, reduced Quality of Care and poor Patient Reported Outcomes

Study Details

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumors (ex: lung, head, neck, thyroid, cervical, breast, bladder, colon, and rectal cancers) in rural patients.

Key Dates

Start date

Sep 1, 2022

Status verified

Feb 2026

Primary completion

Jan 1, 2027

Completion

Jun 30, 2027

Study Design

Enrollment

320 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Active Comparator: CARES Intervention
  All participants will complete surveys to assess Quality of Care and Patient Reported outcomes at baseline, 3 months and 6 months. The CARES intervention will include a maximum of 10 navigation and 10 counseling sessions delivered over approximately a 6- month period delivered by oncology nurse navigators and master's level counselors. Sessions will be scheduled to correspond with key transition points during treatment and may be held in person, virtually, or by phone.
• No Intervention: Usual Care
  All participants will complete surveys to assess Quality of Care and Patient Reported Outcomes. Patients will receive a standardized list of resources.

Primary Outcome Measure

Time to care [ Time Frame: From study start to study end (6 months) ]

Central Contacts

• Jennifer V Gonzalez, MS
  3037246278
  [email protected]
• Tatiana Gerena, MPH
  303-724-5439
  [email protected]

Locations (14)

Find similar trials in Aurora, CO

Related Studies

• Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
  Recruiting · University of Colorado, Denver · Aurora, Colorado
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  PHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
• Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
  PHASE3 · Recruiting · Rocky Mountain Cancer Centers · Aurora, Colorado
• The Immune System's Response to Young Women's Breast Cancer
  Recruiting · University of Colorado, Denver · Aurora, Colorado